Progress toward therapeutic application of interferons, 1979-1983
- PMID: 6208992
- DOI: 10.1002/1097-0142(19841201)54:2+<2770::aid-cncr2820541425>3.0.co;2-0
Progress toward therapeutic application of interferons, 1979-1983
Abstract
Interferons differ chemically and biologically from other modalities of cancer treatment. They are proteins that inhibit viral replication, influence subcellular processes, slow cellular proliferation, affect cell differentiation, and modulate immune responses. These regulatory effects on cell function undoubtedly underlie the effects of interferons in malignant disease. As a result of efforts by academia, industry, governments, and organizations such as the American Cancer Society, significant progress has been made over the past 5 years in elucidating structure, improving production, and defining clinical applications of interferons for both virus and malignant disease.
Similar articles
-
The actions of interferon are potentiated at elevated temperature.Nature. 1978 Aug 3;274(5670):508-10. doi: 10.1038/274508a0. Nature. 1978. PMID: 307691 No abstract available.
-
Interferons with special emphasis on the immune system.Adv Immunol. 1983;34:97-140. doi: 10.1016/s0065-2776(08)60378-8. Adv Immunol. 1983. PMID: 6195895 Review. No abstract available.
-
[Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].Eksp Onkol. 1986;8(3):44-6. Eksp Onkol. 1986. PMID: 2424715 Russian.
-
Interferon treatment of human neoplasia.Adv Cancer Res. 1986;46:1-265. Adv Cancer Res. 1986. PMID: 2425561 Review. No abstract available.
-
Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action.J Gen Virol. 1981 Jan;52(Pt 1):177-81. doi: 10.1099/0022-1317-52-1-177. J Gen Virol. 1981. PMID: 6167662
Cited by
-
Treatment of basal cell carcinoma with intralesional interferon alpha-2b.J R Soc Med. 1991 Sep;84(9):524-6. doi: 10.1177/014107689108400907. J R Soc Med. 1991. PMID: 1941852 Free PMC article. Clinical Trial.
-
Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines.J Neurooncol. 1996 Dec;30(3):213-23. doi: 10.1007/BF00177272. J Neurooncol. 1996. PMID: 8943096
-
The role of interferons in the treatment of malignant neoplasms.Yale J Biol Med. 1989 May-Jun;62(3):271-90. Yale J Biol Med. 1989. PMID: 2479178 Free PMC article. Review.
-
Intralymphatic infusion of interferon in patients with lymph nodal metastases from melanoma of the lower limbs.Cancer Chemother Pharmacol. 1989;24(6):393-4. doi: 10.1007/BF00257450. Cancer Chemother Pharmacol. 1989. PMID: 2477165
-
Normal human epidermis contains an interferon-like protein.J Cell Biol. 1986 Oct;103(4):1349-54. doi: 10.1083/jcb.103.4.1349. J Cell Biol. 1986. PMID: 3771639 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous